Patent · US Active

Biomarkers for the identification of prostate cancer and methods of use

US10982285B2 · kind B2 · utility

0Cited by

0References

11Claims

0Family size

Assignees

Duke University · US
The George Washington University · US

Inventors

Jennifer Freedman · Durham, US
Yanru Wang · Beijing, CN
Hongliang Liu · Qinzhou City, CN
Qingyi Wei · Durham, US
Daniel George · Durham, US
Steven R. Patierno · Falls Church, US
Bi-Dar Wang · Potomac, US
Norman H. Lee · Dayton, US

Key dates

Filing date	Nov 4, 2016
Grant date	Apr 20, 2021
Priority date	—
Expiry date	Mar 14, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12Q2600/156
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure provides biomarkers for the identification of prostate cancer and methods of use. The present disclosure also provide biomarkers that can be used for determining risk of developing prostate cancer, aggressiveness of prostate cancer and survival rate for subpopulations of African American males or non-Hispanic white males.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.